Cargando…

Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype

Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance. We hypothesized that SAA serum levels would be higher in sarcoidosis compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beijer, Els, Roodenburg-Benschop, Claudia, Schimmelpennink, Milou C., Grutters, Jan C., Meek, Bob, Veltkamp, Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998834/ https://www.ncbi.nlm.nih.gov/pubmed/33799927 http://dx.doi.org/10.3390/cells10030585

Ejemplares similares

Latent tuberculosis infection associates with cardiac involvement in patients with sarcoidosis
por: Beijer, Els, et al.
Publicado: (2020)

Detection of Cutibacterium acnes in granulomas of patients with either hypersensitivity pneumonitis or vasculitis reveals that its presence is not unique for sarcoidosis
por: Beijer, Els, et al.
Publicado: (2021)

Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?
por: Beijer, Els, et al.
Publicado: (2019)

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
por: Schimmelpennink, M. C., et al.
Publicado: (2022)

Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis
por: Schimmelpennink, Milou C., et al.
Publicado: (2019)

Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients
por: Beijer, Els, et al.
Publicado: (2021)

Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients
por: Beijer, E., et al.
Publicado: (2020)

Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease
por: Kraaijvanger, Raisa, et al.
Publicado: (2021)

Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
por: Raasing, Lisette RM, et al.
Publicado: (2022)

Immune mechanisms in fibrotic pulmonary sarcoidosis
por: Weeratunga, Praveen, et al.
Publicado: (2022)

Thermal threshold testing: call for a balance between the number of measurements and abnormalities in the diagnosis of sarcoidosis-associated small fiber neuropathy
por: Raasing, Lisette R.M., et al.
Publicado: (2023)

Establishing a Diagnosis of Pulmonary Sarcoidosis
por: Grutters, Jan C.
Publicado: (2023)

ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis Patients
por: Karakaya, Bekir, et al.
Publicado: (2022)

Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis
por: Jeny, Florence, et al.
Publicado: (2021)

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis
por: Bernardinello, Nicol, et al.
Publicado: (2021)

The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?
por: Kraaijvanger, Raisa, et al.
Publicado: (2022)

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
por: Moll, Sofia A., et al.
Publicado: (2020)

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren’s Syndrome and Alters Receptor Expression as well as Functional Response
por: Karakaya, Bekir, et al.
Publicado: (2021)

Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
por: Kraaijvanger, Raisa, et al.
Publicado: (2023)

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases
por: Moll, Sofia A., et al.
Publicado: (2022)

Pulmonary hypertension complicating pulmonary sarcoidosis
por: Huitema, M. P., et al.
Publicado: (2016)

The right upper lobe bronchus angle: A tool for differentiating fibrotic and non-fibrotic sarcoidosis
por: Salvatore, Mary, et al.
Publicado: (2020)

Localized Hepatosplenic Sarcoidosis with an Elevated Serum CA-125 Level
por: Herati, Ramin S., et al.
Publicado: (2010)

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population
por: Kahlmann, Vivienne, et al.
Publicado: (2021)

Computed Tomography Images of Fibrotic Pulmonary Sarcoidosis Leading to Chronic Respiratory Failure
por: Sawahata, Michiru, et al.
Publicado: (2020)

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
por: Kraaijvanger, Raisa, et al.
Publicado: (2020)

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
por: Keijsers, Ruth G.M., et al.
Publicado: (2020)

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
por: Peters, Bas J. M., et al.
Publicado: (2021)

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
por: Mathijssen, H., et al.
Publicado: (2021)

Sarcoidosis Phenotypes
por: Francesqui, Joel, et al.
Publicado: (2021)

Diagnostic value of elevated serum carbohydrate antigen 125 level in sarcoidosis
por: Zhang, Qian, et al.
Publicado: (2022)

A case highly suspicious of isolated cardiac sarcoidosis
por: Huitema, M. P., et al.
Publicado: (2016)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension
por: Groen, Karlijn, et al.
Publicado: (2022)

Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
por: Mathijssen, H., et al.
Publicado: (2020)

Identifying a core outcome set for pulmonary sarcoidosis research – the Foundation for Sarcoidosis Research – Sarcoidosis Clinical OUtcomes Taskforce (SCOUT)
por: Harman, Nicola L., et al.
Publicado: (2022)

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker
por: Kehlet, S.N., et al.
Publicado: (2017)

Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis
por: Aida-Yasuoka, Keiko, et al.
Publicado: (2013)

Outcomes in pulmonary sarcoidosis: results of a newly implemented prednisone protocol
por: Kampstra, Nynke A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_81u73s2cdu8e40hahfmna6uttn